US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74

-0.0600-0.34%

Post-market: 17.800.0600+0.34%19:30 EDT

Volume:28.78K

Turnover:509.79K

Market Cap:104.67M

PE:- -

High:17.93

Open:17.89

Low:17.60

Close:17.80

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.55

T/O Rate:0.49%

Dividend:0.71

Dividend Rate:4.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer

Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC

THOMSON REUTERS

China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt

Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer

THOMSON REUTERS

Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint

THOMSON REUTERS

Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate

THOMSON REUTERS

WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/KURE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.74,"timestamp":1789156800000,"preClose":17.8,"halted":0,"volume":28778,"hourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"delay":0,"changeRate":-0.00337078651685406,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Market Closed","change":-0.06,"latestTime":"09-11 16:00:00 EDT","open":17.89,"high":17.93,"low":17.6,"amount":509789.147232,"amplitude":0.018539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.8,"sharesOutstanding":4750002,"nav":17.98,"aum":106101372.73,"dividendRate":0.040293,"bidAskSpread":0.008302,"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"volumeRatio":0.5515710695008692,"impliedVol":0.3113,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5515710695008692,"shares":5900168,"dividePrice":0.7148,"high":17.93,"amplitude":0.018539,"preClose":17.8,"low":17.6,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.74,"eps":0,"divideRate":0.040293,"volume":28778,"delay":0,"ttmEps":0,"open":17.89,"prevYearClose":17.04,"prevWeekClose":18.9,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.91,"twentyDayClose":18.66,"sixtyDayClose":14.875},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1149059268","title":"Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1149059268","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149059268?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:02","pubTimestamp":1787724134,"startTime":"0","endTime":"0","summary":"Hong Kong healthcare stocks continued their upward momentum on August 26, with innovative drug developers taking over the leadership baton from the CXO sector. Cansino Biologics Inc. soared more than...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU0244354667.USD","LU2097828631.EUR","BK1574","LU0455707207.USD","LU2488822045.USD","LU1188198961.HKD","LU2097828557.USD","LU2097828805.USD","LU2328871848.SGD","688185","01801","FLHK","LNGR","159646","LU2097828714.EUR","HK0000165453.HKD","BK1589","LU2097828474.EUR","LU2242644610.SGD","LU0463099449.HKD","BK0239","LU0326950275.SGD","MEDX","BK1161","IBBQ","159992","KURE","06978","LU0502904849.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662640467","title":"China, HK Stocks Track Global Tech Rebound; Gold Miners Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2662640467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662640467?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:27","pubTimestamp":1787718464,"startTime":"0","endTime":"0","summary":"China, HK stocks track global tech rebound; gold miners rallySHANGHAI, August 26 (Reuters)-China and Hong Kong stocks advanced on Wednesday, tracking a broader rebound in global markets as sentiment i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JGRO","LU2552382215.SGD","IE00B7SZL793.SGD","LU0308772762.SGD","LU0353189680.USD","LU1066051811.HKD","LU0106252389.USD","LU2860962120.EUR","NVDW","LU0965509010.AUD","IE0001KFT4U8.USD","LU1778281490.HKD","LU1037948897.HKD","LU2602419157.SGD","LU0234572021.USD","LU0651947912.USD","LU1719994722.HKD","BK1589","COHC","LU0359201612.USD","LU0210528500.USD","LU0345769128.USD","LU0873338254.USD","LU2097344357.USD","LU2125909247.SGD","LU0228367735.SGD","LU1923623000.USD","LU0784639295.USD","LU0347712357.USD","LITC","BK4592","LU1868836757.USD","LU0831103253.SGD","IE0004086264.USD","LU2360106780.USD","SG9999002232.USD","IE00B5949003.HKD","LU0072462343.USD","LU0417516571.SGD","LU2272731600.USD","LU0197773673.USD","LU1400636491.USD","LU1105468828.SGD","IE00B4YYXB79.USD","IE00BZ08YR35.GBP","LU1548497426.USD","LU0127658192.USD","LU0316494557.USD","LU1211504680.USD","LU1880398471.USD","LU2403377893.USD","LU2065171311.SGD","SG9999004303.SGD","LU2244417387.USD","LU2361045086.USD","LU0700851271.USD","LU1935043023.USD","HK0000914660.USD","LU0107464264.USD","LU0516423091.SGD","LU0348816934.USD","LU2023250330.USD","LU0886674414.USD","LU2097828805.USD","LITG","LU2168564222.USD","ALBmain","LU0205194284.USD","LU0795875086.SGD","LU2449936058.SGD","LU0823040885.USD","SG9999015978.USD","LU1935043536.SGD","LU0737861772.HKD","LU0828237510.HKD","CMAG","LU0957791311.USD","LU0106261612.USD","LU0762541174.USD","NVDA","LU1048596156.SGD","LU2293587155.HKD","LU0170899867.USD","NVDU","LU1934455194.USD","LU2097344431.USD","SG9999015358.SGD","LU1989772840.SGD","LU0862451837.USD","LU0133085943.USD","LU0642271901.SGD","BK4612","LU0640798160.USD","LU0964807845.USD","LU2237438978.USD","LU0053666078.USD","LU0029874905.USD","IE0009G5SDU7.USD","LU0345770993.USD","GB00BDT5M118.USD","LU1232071149.USD","LU0128522744.USD","IE0034235303.USD","LU0469268626.HKD","IE00B5TLWC47.USD","VGT","BK4020","LU0314109678.HKD","LU0130103400.USD","LU0868486357.SGD","LU1813983027.USD","IE00BWXC8680.SGD","BK1501","LU1642822529.SGD","LU1568876251.USD","BK4554","IE000W1ABFV2.USD","LU0138981039.USD","LU2347655156.SGD","LU2125154778.USD","07388","CHPX","LU0057025933.USD","LU1429558221.USD","LU0109392836.USD","FDNI","IE00BN29S564.USD","BK1618","LU0203202063.USD","LU1366333091.USD","HK0000914686.HKD","LU1803068979.SGD","LU0205193047.USD","LU0158827948.USD","LU1951198990.SGD","BK4527","07200","LU1048588211.SGD","BK4550","LU1496350502.SGD","LU0708995153.HKD","LU0689472784.USD","IE00BFSS7M15.SGD","LU2250418816.HKD","IE00BFSS8Q28.SGD","LU0117841782.USD","NVDL","LU1116320737.USD","LU0181495838.USD","LU0240878834.USD","LU2087621335.USD","LU2213496289.HKD","LU2473716301.USD","IETC","LU0594300179.USD","KURE","LU0823434740.USD","LU2476274308.USD","LU0979878070.USD","LU1674673428.USD","IE000ITXATA3.USD","LU1127390331.HKD","GAMR","LU1084165304.USD","LU0449509016.USD","LU0082616367.USD","LU0353189763.USD","CXSE","LU0345768153.USD","LU0823041008.USD","LU0572939691.SGD","HK0000532082.HKD","HK0000286598.CNH","LU0061474705.USD","LU0868494708.USD","LAZR","SG9999014567.USD","LU0634319403.HKD","HK0000819398.USD","SGXZ23171101.USD","LU0588545490.SGD","LU1720051017.SGD","LU1804176565.USD","LU2237443465.HKD","LU1956131251.USD","LU0762540952.USD","LU0049853897.USD","LU0328353924.USD","LU2488822045.USD","LU2931357623.SGD","LU1831875114.USD","IE00BKPKM429.USD","LU0197773160.USD","LU1961090484.USD","LITZ","LU2361044865.SGD","LU2394011477.USD","LU1821325948.USD","LU0323239441.USD","LU2047632596.USD","LU0543330566.HKD","LU0310800379.SGD","LU0516423174.USD","BK1502","LU2506951792.HKD","2NVD.UK","SG9999015945.SGD","IE00BZ08YS42.EUR","LU2322448957.HKD","LU0630378429.USD","IE0004445239.USD","SG9999002828.SGD","IE000YTNTUN2.SGD","LU0061477393.USD","LU0310799852.SGD","LU0672654166.SGD","LU1655091459.SGD","LU0531970944.HKD","LU1814569148.SGD","LU0545039389.USD","SG9999001689.USD","IE00B775H168.HKD","LU2054465674.USD","LU2242644610.SGD","BK1608","SOXX","LU0143863784.USD","LU1251922891.USD","LU1261432733.SGD","LU2328871848.SGD","IE00BJTD4N35.SGD","LU0124676726.USD","LU1435385759.SGD","LU1769817096.USD","LU2148611432.USD","IE00BQXX3C00.GBP","LU0441854154.USD","LU2168564065.EUR","LU2471134952.CNY","LU2097828714.EUR","LU2279689827.SGD","LU2265009873.SGD","LU1328615791.USD","LU2361044949.HKD","LU0918141705.HKD","LU1969619763.USD","LU2417539215.USD","LU0828237940.HKD","LU1366334578.USD","LU0198837287.USD","LU1721428933.USD","LU0094547139.USD","LU2471134879.HKD","03037","LU0985320562.USD","LU0502904849.HKD","LU2360032135.SGD","LU1202635105.USD","BK4551","LU0320764243.SGD","LU0211327993.USD","LU0154236417.USD","LU0417516902.SGD","LU1880383440.USD","METV","HK0000165453.HKD","LU1282648689.USD","LU1914381329.SGD","LU0348805143.USD","LU2954938101.SGD","IE00BMPRXN33.USD","LU2476274720.SGD","LU1366334651.USD","LU0259732245.USD","LU0169518387.USD","LU0820562030.AUD","LU2039709279.SGD","IE00BK4W5L77.USD","LU2023250504.SGD","LU1699723380.USD","BKF","LU1633808545.USD","LU1815333072.USD","NVDG","LU0326950275.SGD","LU2461242641.AUD","LU0254981946.USD","IE00BZ08YT58.USD","LU1267930490.SGD","SG9999001093.SGD","LU0823413587.USD","LU1303224171.USD","HK0000107257.USD","LU0175139822.USD","LU0211328371.USD","LU0080751232.USD","LU1794554557.SGD","LU0463099449.HKD","LU1496350171.SGD","LU1153585028.USD","LU2237443895.HKD","LU2637965513.SGD","LU2487616109.SGD","LU2236285917.USD","BK1583","LU0054450605.USD","LU0577902454.USD","NVDS.UK","SG9999000418.SGD","SG9999004220.SGD","LU0965509283.SGD","LU0276348264.USD","82800","IE00B19Z4B17.USD","LU0342679015.USD","NULC","LU0187121727.USD","LU0274383776.USD","LU0708995401.HKD","SGXZ62798434.SGD","IE00B3SWFQ91.USD","LU1551013425.SGD","LU0348827113.USD","LU2100268510.USD","LU0081259029.USD","IE00BZ199S13.USD","LU0395794307.EUR","LU1323610961.USD","CLSE","LU0949170772.SGD","LU1993786604.SGD","LU0543330483.HKD","BK4579","LU0577902371.SGD","LU2045819591.USD","IE0031619046.USD","LU0215105999.USD","LU1923622291.USD","LU1064131342.USD","LU0261947096.USD","LU2462157665.USD","IE0034224299.USD","LU1989764664.SGD","LU2168563687.JPY","LU2271345857.HKD","LU2430703178.SGD","LU1807302812.USD","SG9999015341.SGD","IE00B19Z9505.USD","IE0034235188.USD","LU1868836591.USD","FTEC","LU0651946864.USD","LU0541502299.USD","LU1880398554.USD","LU0477156797.USD","LU1674673691.USD","LU1044875133.USD","LU0210527791.USD","LU0661504455.SGD","LU0762542818.HKD","07788","LU1935042215.USD","LU1989764748.USD","LU2242649171.HKD","LU0607220059.USD","LU1770036033.HKD","LU0861579265.USD","LITE","LU0052750758.USD","SG9999014542.SGD","LU2065170008.USD","LU2092937148.SGD","BK4548","LU0329678337.USD","LU1551013342.USD","LU1852331112.SGD","NVDY","LU2778985437.USD","IE00B4JS1V06.HKD","SG9999014674.SGD","LU2756315664.SGD","LU0149721374.USD","IE0009356076.USD","LU0417516738.SGD","LU1282649141.HKD","SGXZ81514606.USD","LU2125909916.SGD","LU0823421416.USD","LU1515016050.SGD","BK4148","BK1142","LU1144417596.USD","IE00B1XK9C88.USD","LU0320764599.SGD","LU1670756490.USD","LU2108987350.USD","COHH","TRFK","LU1023057109.AUD","LU2347655073.USD","SG9999018857.SGD","HHImain","LU0320764755.SGD","LU2433249047.HKD","LU0051755006.USD","LU2552382058.USD","LU0499858438.USD","LU1791710582.SGD","LU0823039010.USD","LU2505996509.AUD","LU2125909593.SGD","IE00BDCRKT87.USD","LU0588545730.USD","SPRX","LU1974910355.USD","LU0048388663.USD","LU2106854487.HKD","LU1917777945.USD","LU1861220033.SGD","LITX","LU0128525929.USD","LU0210536198.USD","SG9999000327.SGD","SG9999014880.SGD","IE00BZ1G4Q59.USD","LU0819123356.HKD","LU2226246903.HKD","LU0856984785.SGD","IE00B0169N27.USD","LU0077335932.USD","LU1242518857.USD","BK4608","LU2097829019.USD","LU0240877869.USD","LU0819121731.USD","SMH","LU0047713382.USD","IE00BPRC5H50.USD","FAI","LU0174119429.USD","LU0724617625.USD","LU0608807433.USD","LU0096362180.USD","LU0965509101.SGD","LU1815336760.USD","LU1988902786.USD","SOXQ","LU0449515922.USD","LU0871576103.HKD","LU1316542783.SGD","BK1575","LU0683600562.USD","LU1115378108.SGD","IE00BKVL7J92.USD","LU0820561909.HKD","LU2290526834.HKD","LU3063872942.SGD","LU0882574139.USD","BK1521","IE00B5MMRT66.SGD","LU2211815571.USD","LU0293314216.USD","LU1145028129.USD","LU0593848301.USD","SG9999001903.USD","LU0648000940.SGD","LU0345768740.USD","LU2592432038.USD","LU2543165471.USD","LU2413666699.HKD","SHOC","SG9999006514.SGD","LU1044874839.SGD","LU0726765562.USD","LU1732799900.SGD","LU2750360997.AUD","IE00B775SV38.USD","NVD2.UK","LU0267386448.USD","LU0012050646.USD","LU0149534421.HKD","LU2456880835.USD","LU0588545904.SGD","ROM","IE0005OL40V9.USD","LU0048597586.USD","LU0608807946.USD","LU1066051498.USD","LU1645745479.HKD","LU1400636657.SGD","LU2065171402.SGD","BK1610","HSTECH","ILDR","LU2133065610.SGD","BK4157","LU0823038988.USD","SMHX","LU1282649067.USD","LU1481107354.HKD","BK4529","LU0865486749.SGD","LU2152927971.USD","SG9999014914.USD","LU1934455863.HKD","THMR","SG9999002224.SGD","LU2505996681.GBP","LU1282649810.SGD","LU1688375341.USD","COHQ","LU0143551892.USD","BK4141","LU0231483743.USD","IE00BQXX3D17.EUR","LU2087625088.SGD","BK4532","LU0912757837.SGD","LU2168564149.EUR","IE00BMPRXQ63.HKD","LU2237957811.SGD","LU1983260115.SGD","LU2286300806.USD","LU2294711473.HKD","IE00BMPRXR70.SGD","LU2063271972.USD","LU1810669033.SGD","LU2089985449.USD","IE00BJLML261.HKD","LU0675040207.SGD","LU0788109477.HKD","LU0831093199.SGD","IE0003895053.USD","LU2999663052.SGD","USXF","LU0228659784.USD","LU2237443549.SGD","LU0823397285.USD","LU0650527681.SGD","LU2420271590.USD","LU1718418525.SGD","LU1979441026.SGD","LU0048580855.USD","LU1323998911.USD","SGXZ90724238.SGD","LU2097828474.EUR","LU0210533765.USD","NVC","EGGY","LU0289960550.SGD","BK1584","BK1586","LU1282651121.HKD","LU1923622614.USD","LU1571399168.USD","LU1839511570.USD","LU1201861165.SGD","LITU","LU1732800096.USD","LU0572940350.SGD","BK1161","SG9999015986.USD","LU0476273544.USD","LU1934455277.USD","BK4567","LU1861127337.USD","IE0003U64NQ7.SGD","IE00B19Z8W00.USD","LU0256863811.USD","LU0029875118.USD","LU0069063385.USD","SG9999002463.SGD","LU2237443622.USD","LU0106959298.USD","LU0890818403.SGD","LU2125910849.SGD","LU0605514214.HKD","SGXZ80539844.SGD","EFIV","LU0287142896.SGD","LU0345775950.USD","LU2272731782.SGD","MHImain","LU1051769294.HKD","ARTY","NVD3.UK","LU2097828631.EUR","LU0345769631.USD","LU0957808578.USD","BK4585","LU0348788117.USD","LU0251144936.SGD","LU0251132253.USD","LU0540923850.HKD","IE0008368304.USD","LU1003077747.HKD","LU1244550494.USD","TYLG","LU0572944931.SGD","LU0390134368.USD","LU1808992512.USD","IE00B3M56506.USD","LU0329678170.USD","HK0000320223.HKD","LU0140636845.USD","LU0348783662.USD","LU0786609619.USD","LU1069347547.HKD","LU2896262040.SGD","LU0011850046.USD","LU0117844026.USD","NVDO","NVDX","LU0320765059.SGD","LU1242518931.SGD","LU0898667661.SGD","ESUM","LU1224709979.USD","BK4587","LU0791591158.USD","LU1861215975.USD","LU2750360641.GBP","LU2491050154.USD","LU0323240290.USD","LU0235996351.USD","LU1244550221.USD","LU0043850808.USD","LU1035773651.USD","LU0417517546.SGD","LU0553294199.USD","NVD","SGXZ86797644.SGD","LU0211977185.USD","LU0307460666.USD","BK4605","IE00B543WZ88.USD","LU0106261372.USD","LU0689626769.HKD","COHR","LU2491050071.SGD","SG9999002562.SGD","IE0032431581.USD","LU0348723411.USD","LU2552382132.HKD","LU1960683339.HKD","513600","09988","LU0265550359.USD","LU2462591277.SGD","LU2491049909.HKD","AGOX","02800","LU2462591350.SGD","LU0589944569.HKD","LU2125910500.SGD","LU0264606111.USD","LU2360107168.USD","LU0164872284.USD","LU1691799644.USD","LU0456827905.SGD","LU1037948541.HKD","LU0196878994.USD","LU0672654240.SGD","LU0244354667.USD","LU2322448791.USD","LU2471134523.USD","ESLG","BK1517","LU2249611893.SGD","LU1119994496.HKD","LU0494093205.USD","LU0348735423.USD","SG9999014575.USD","LU2083900584.USD","LU0132412106.USD","LU0327786744.USD","FDTX","LU1116320901.HKD","SGXZ51526630.SGD","LU0708995583.HKD","LU2746668974.SGD","SG9999014898.SGD","LU1224444064.USD","HK0000306685.HKD","LU0611395673.USD","LU2191332357.HKD","LU0348814723.USD","LU0225283273.USD","LU0472753341.HKD","IE00B7KXQ091.USD","FOTO","NVII","LU0823397103.USD","LU0039217434.USD","LU0588546209.SGD","LU2237957902.USD","IE00B1BXHZ80.USD","LUMA","LU0109391861.USD","HBBD.SI","LU2111349929.HKD","LU2264538146.SGD","LU0256863902.USD","LU1992135472.HKD","SG9999001226.SGD","LU1880383366.USD","LU0456846285.SGD","LU0359201885.HKD","LU0315178854.USD","LU2242650005.HKD","IE00BJJMRY28.SGD","LU2247934214.USD","BK4533","TTXU","IE00BHPRN162.USD","LU2430703251.USD","LU0630378692.HKD","LU0173614495.USD","LU0396098781.USD","LU1196710864.SGD","XLK","LU0056508442.USD","LU0455707207.USD","SG9999015952.SGD","LU0011963245.USD","LU0323591593.USD","LU0345776255.USD","LU0561508036.HKD","LU0594300419.USD","LU0821914370.USD","IE00BDRTCR15.USD","LU0516422952.EUR","LU1868837300.USD","IE00BKDWB100.SGD","LU0787776722.HKD","LU1568876335.HKD","03115","LU0084288322.USD","LU0096374516.USD","LU2294711713.HKD","SGXZ31699556.SGD","TTEQ","TEK","09115","LU2463028550.USD","LU0823434583.USD","LU2458330169.SGD","LU1642822792.SGD","LU1188198961.HKD","LU0795875169.SGD","LU0106259558.USD","LU0203201768.USD","LU0348784397.USD","LU0165289439.USD","LU0516422366.SGD","LU1720050803.USD","01801","HSI","LU0943347566.SGD","LU0158827781.USD","LU1935042991.SGD","07300","89988","LU1868837136.USD","IE00BYXW3230.USD","SG9999001051.SGD","LU0210526637.USD","LU0557290698.USD","LU1066053197.SGD","LU2125909759.SGD","SNVD.UK","IE00BQXX3F31.USD","LU0823413660.USD","LU0823426308.USD","IXN","LU0444971666.USD","LU0820561818.USD","AIFD","LU0054237671.USD","LU0737861699.HKD","LU0048584097.USD","LFGY","IE00B66KJ199.SGD","LU2028103732.USD","LU0791590937.USD","LU2089284900.SGD","LU1623119135.USD","WISE","LU0942090050.USD","SG9999006597.SGD","LU0238689110.USD","LU2089283258.USD","MCHmain","HK0000306701.USD","LU0648948544.HKD","KWEB","LU0079474960.USD","LU2746668461.USD","DIPS","83115","LU2471134796.USD","LU0640476718.USD","IE00BD6J9T35.USD","LU0315179316.USD","LU0097036916.USD","SG9999017495.SGD","LU1504937902.USD","IE0004091025.USD","LU0006306889.USD","IE00B19Z8X17.USD","LU0531971595.HKD","SPTE","LU0918141887.USD","IE00BK4W5M84.HKD","BK4503","LU0234570918.USD","NVIW.SI","03419","LU2077746001.SGD","LU2065169927.USD","SG9999014559.SGD","LU0862451753.SGD","NVYY","NVDS","LU2237443978.SGD","LU2125154935.USD","LU1244550577.SGD","LU1712237335.SGD","SG9999014906.USD","LU1044876610.USD","LU1791710400.SGD","LU1328277881.USD","SNVDAmain","LU1720051108.HKD","LU1981816686.USD","HK0000151867.HKD","HK0000304805.HKD","IE0004445015.USD","LU0466842654.USD","LU0738911758.USD","IE000KEQY171.SGD","BK4534","LU0488056044.USD","LU2430703095.HKD","SG9999001424.SGD","BK1588","SGXZ99366536.SGD","IE00BJTD4V19.USD","LU0265550946.USD","LU1769817179.HKD","LU2257852520.SGD","LU0528227936.USD","LU0577902611.USD","LU2237443382.USD","LU0354030511.USD","LU0516422440.USD","LU1066051225.USD","LU2092627202.USD","LU0214875030.USD","LU0708994859.HKD","SNPE","LU0164880469.USD","BK4614","LU0289739343.SGD","LU2357125470.USD","07500","LU2326559502.SGD","HK0000304797.USD","SG9999000459.SGD","LU0157215616.USD","LU0029864427.USD","CNEQ","LU0261950983.USD","LU0072462426.USD","LU1992135399.USD","LU0266013472.USD","ABFL","LU0289961442.SGD","LU1048484197.HKD","LU1989772923.USD","LU1366192091.USD","LU0823421333.USD","LU2097828557.USD","BK4598","SOXY","LU0370786039.SGD","LU0797268264.HKD","COHX","LU0577902298.EUR","LU0444973449.USD","LU1069344957.HKD","LU2452424414.USD","LU0348825331.USD","LU0130518102.USD","LU0823414551.USD","LU3102509885.SGD","LU1051768304.USD","BK4581","LU0163747925.USD","LU0499858602.USD","LU2413666426.HKD","IE00B3S45H60.SGD","NVDQ","LU2399975544.HKD","LU2756315318.SGD","LU0823426480.USD","LDEM","LU0511384066.AUD","LU1280957306.USD","LU0143863198.USD","IE00B0JY6N72.USD","LU0359202008.SGD","02833","3NVD.UK","LU0061474960.USD","LU1282651048.USD","ANV","BK4549","LU0431992006.USD","BK4543","IE000Q6AESB8.SGD","LU1267930730.SGD","LU2458330243.SGD","LU1400636574.HKD","LU0719512351.SGD","LU2023251221.USD","LU1935042488.USD","LU0096364046.USD","LU0348783233.USD","LU1629891620.HKD","LU0889565833.HKD","LU1868836914.USD","IE0034235295.USD","LU0868494617.USD","LU2381873111.SGD","LU2357305700.SGD","LU0965508806.USD","LU2168564495.EUR","LU0384037296.USD","LU0823414478.USD","AIPI","USD","BK1249","LU0577902538.SGD","LU1770034418.SGD","LU2272731865.HKD","BK4588","CHAT","LU1868837565.USD","IE00BJJMRX11.SGD","LU1267930573.SGD","VT","LU0164865239.USD","LU0229945570.USD","LU0345770308.USD","BK1591","LU1035775433.USD","NVDB","LU0061475181.USD","SG9999018865.SGD","LU1439103000.SGD","BK1615","LU1951200564.SGD","LU0128522157.USD","BABA","LU0541501648.USD","NVDD","LU0070217475.USD","LU1868838027.USD","LU2087589342.USD","HK0000320264.USD","LU0354030438.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276478","title":"Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276478?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:16","pubTimestamp":1787717785,"startTime":"0","endTime":"0","summary":"Hong Kong's SSY Group H1 profit rises on infusion solutions growthOverviewHong Kong pharmaceutical maker's H1 revenue rose 9.9% yr/yr to HK$2,361 mlnNet profit attributable to shareholders rose 13% to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828557.USD","LU0455707207.USD","LU0463099449.HKD","LU2097828631.EUR","LU0244354667.USD","BK1583","LU2328871848.SGD","BK1589","01801","LU2460026573.USD","LU0326950275.SGD","02005","LU1188198961.HKD","LU1969619763.USD","LU0502904849.HKD","HK0000165453.HKD","BK1191","KURE","LU2488822045.USD","LU2097828474.EUR","LU2097828714.EUR","LU2242644610.SGD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","HK0000165453.HKD","BK1593","IE00B031HY20.USD","LU1226287529.USD","LU0463099449.HKD","BK1583","LU1960683339.HKD","00460","LU1152091168.USD","LU0314109678.HKD","LU2097828805.USD","LU2097828474.EUR","LU2242644610.SGD","IE00B5MMRT66.SGD","LU0502904849.HKD","SG9999004220.SGD","LU0072913022.USD","IE0008369823.USD","LU0067412154.USD","LU1188198961.HKD","LU1226288170.HKD","LU1152091754.HKD","LU2488822045.USD","LU1328277881.USD","LU1226288253.USD","IE00BZ08YS42.EUR","01093","LU1008478684.HKD","LU0880133367.SGD","BK1515","LU1813983027.USD","BK1191","BK1161","LU1969619763.USD","LU1807302812.USD","LU2328871848.SGD","LU0244354667.USD","BK1600","LU2039709279.SGD","BK0239","LU2097828714.EUR","LU0501845795.SGD","LU2097828631.EUR","BK1589","LU0140636845.USD","LU0455707207.USD","IE00B543WZ88.USD","688428","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154655464","title":"Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1154655464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154655464?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717221,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index kicked off the morning session with a 0.68% gain, advancing 174 points to reach 25,685 points, while the tech-heavy Hang Seng Tech Index climbed a more robust 1.58%....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1516","BK1568","LU0244354667.USD","03115","03993","LU1023057109.AUD","LU2039709279.SGD","03423","01258","IE00B5MMRT66.SGD","LU2351347302.SGD","LU0149721374.USD","BK1242","LU0561508036.HKD","LU2929501877.USD","MCHmain","LU0348827113.USD","IE00BVYPNQ40.USD","LU0708995583.HKD","HTImain","01112","BK1564","LU0164880469.USD","LU0359202008.SGD","LU1880383440.USD","LU1961090484.USD","LU0417516738.SGD","BK1515","LU0348784397.USD","LU2045819591.USD","BK1149","LU0320764599.SGD","BK1147","06099","LU0463099449.HKD","02313","LU0634319403.HKD","LU1720050803.USD","02575","82800","SG9999004311.SGD","BK1574","LU1481107354.HKD","LU2213484517.USD","LU2476274720.SGD","IE00B29SXG58.USD","03417","06969","09926","LU0540923850.HKD","00358","LU0594300179.USD","LU1794554557.SGD","LU2476274308.USD","LU0605514214.HKD","LU1048596156.SGD","BK1233","09067","600362","HSImain","603993","603083","SG9999014674.SGD","IE0031814852.USD","BK1553","IE00BZ08YR35.GBP","LU0348735423.USD","IE00BYV24P56.USD","LU0181495838.USD","LU2488822045.USD","LU2125910500.SGD","LU1102505929.USD","LU0607220059.USD","02837","03037","LU1880383366.USD","LU1831875114.USD","LU0052750758.USD","IE00BVYPNP33.GBP","03088","LU2399975544.HKD","83115","SG9999002828.SGD","09115","LU0348766576.USD","LU0405327148.USD","LU0348825331.USD","LU0828237940.HKD","07500","09088","BK1592","IE00B031HY20.USD","BK1190","IE00BZ08YS42.EUR","LU0359201612.USD","BK1206","03908","02800","07226","600999","LU2187417386.USD","513600","BK1191","LU1328277881.USD","BK1161","BK1521","HHImain","BK1580","LU1188198961.HKD","LU0359201885.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1102505762.USD","SG9999002950.SGD","LU0326950275.SGD","LU0650527681.SGD","IE00BGHQDM52.EUR","07300","03067","01828","LU0594300419.USD","02833","06166","KURE","IE0008369823.USD","BK1501","HSI","BK1589","IE00BPRC5H50.USD","LU0862451753.SGD","LU1813983027.USD","601995","03033","LU0149534421.HKD","03419","LU0821914370.USD","688185","06185","LU0314109678.HKD","LU0405327494.USD","LU0348767384.USD","BK1240","LU2778985437.USD","BK1227","LU0890818403.SGD","BK1184","03032","LU0417516902.SGD","LU0140636845.USD","BK1594","LU0417516571.SGD","IE00B031J352.USD","HSTECH","IE00BMCWC346.EUR","07200","HK0000286598.CNH","LU0348783233.USD","BK1237","BK1513","IE0008368742.USD","06831","07552","BK1597","LU0862451837.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128522297","title":"Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1128522297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128522297?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:38","pubTimestamp":1787711889,"startTime":"0","endTime":"0","summary":"Mainland Chinese equities extended gains on August 26, with all three major indices moving higher in early trading. Precious and base metals sustained their upward momentum, while brokerages and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03419","LU1781817850.SGD","LU2242644610.SGD","BK0012","02837","LU0501845795.SGD","LU0067412154.USD","LU2328871848.SGD","LU1993786604.SGD","09088","07552","BK1589","BK0028","BK0188","LU1188198961.HKD","LU2097828474.EUR","BK0201","02833","000001","LU0880133367.SGD","03033","03417","07200","IE00B0JY6N72.USD","BK1161","LU0072913022.USD","LU0502904849.HKD","09067","KURE","83115","MCHmain","LU1807302812.USD","03032","07300","09115","HHImain","LU0455707207.USD","LU1969619763.USD","03423","07226","BK0278","LU2097828805.USD","HTImain","LU2097828631.EUR","LU2488822045.USD","LU2097828557.USD","LU0463099449.HKD","07500","HSI","LU2097828714.EUR","BK1583","LU0244354667.USD","03115","03067","HK0000165453.HKD","LU1226287529.USD","03088","02800","01801","HSImain","LU1655091616.SGD","82800","BK0187","LU1580142542.USD","HSTECH","03037","LU0326950275.SGD","BK0183","161726","513600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769060","title":"China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769060?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:33","pubTimestamp":1787711596,"startTime":"0","endTime":"0","summary":"BUZZ-China's Akeso jumps on progress of immunotherapy drug for cancer treatment** Shares of China-based drug developer Akeso Inc9926.HKjump 9% to HK$96.9, on track for the biggest one-day pct gain since June 29** Stock hits the highest level since August 20 in the second gaining session** Akeso saysivonescimab plus chemomeets primary endpoint with significant overall survival benefit versus durvalumab plus chemo in phase III clinical study for the first-line treatment of advanced biliary tract cancer** The study met all key secondary endpoints of progression-free survival and objective response rate - Co** YTD, stock down 14.8%, while Hang Seng Biotech Index.HSBIOup 15.7%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU2399975544.HKD","09926","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348766576.USD","LU0348767384.USD","LU2778985437.USD","LU1794554557.SGD","LU0348825331.USD","LU2476274308.USD","LU0561508036.HKD","LU0348827113.USD","LU0417516902.SGD","LU0417516571.SGD","LU1961090484.USD","BK1161","LU0417516738.SGD","LU0348783233.USD","LU0348784397.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0634319403.HKD","LU1720050803.USD","LU2488822045.USD","BK1574","KURE","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","IE00B5MMRT66.SGD","LU1961090484.USD","III","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348825331.USD","BK1161","LU2778985437.USD","LU2476274308.USD","LU0561508036.HKD","LU0348827113.USD","LU0417516902.SGD","LU2476274720.SGD","BK1574","BK4134","LU0417516738.SGD","LU0348766576.USD","09926","LU1720050803.USD","LU2488822045.USD","LU0417516571.SGD","LU0348735423.USD","LU0348767384.USD","LU0540923850.HKD","LU0348784397.USD","LU0348783233.USD","LU0634319403.HKD","LU1794554557.SGD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348783233.USD","LU1794554557.SGD","LU2399975544.HKD","LU0417516738.SGD","LU2476274720.SGD","LU2488822045.USD","LU0417516571.SGD","BK1161","LU0348735423.USD","LU1961090484.USD","LU0348784397.USD","BK1574","LU0561508036.HKD","LU2778985437.USD","LU0348766576.USD","LU0417516902.SGD","LU0348767384.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU0348827113.USD","09926","LU0348825331.USD","LU0540923850.HKD","LU0634319403.HKD","LU1720050803.USD","IE00B543WZ88.USD","KURE","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766696","title":"Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:29","pubTimestamp":1787707747,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says Ivonescimab Plus Chemo Meets Primary EndpointAug 26 (Reuters)-Akeso Inc9926.HK:IVONESCIMAB PLUS CHEMO MEETS PRIMARY ENDPOINT WITH SIGNIFICANT OS BENEFIT IN 1L BTCFurther company coverage:9926.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU2476274308.USD","LU0348767384.USD","IE00B5MMRT66.SGD","LU0348827113.USD","LU0417516738.SGD","LU0417516571.SGD","LU1961090484.USD","LU2488822045.USD","LU1720050803.USD","LU0634319403.HKD","LU1794554557.SGD","LU2399975544.HKD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348784397.USD","LU0348735423.USD","LU0561508036.HKD","LU0348766576.USD","BK1161","KURE","LU2778985437.USD","BK1574","09926","LU0348783233.USD","IE00BPRC5H50.USD","LU0348825331.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114601608","title":"INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1114601608","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114601608?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:28","pubTimestamp":1787707707,"startTime":"0","endTime":"0","summary":"Shares of INNOVENT BIO (01801) opened more than 6% higher on Thursday, extending gains to 6.49% at HK$106.60 with turnover reaching HK$28.73 million in early trading.The rally follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828557.USD","VXUS","LU0455707207.USD","LU0463099449.HKD","LU2097828631.EUR","LU0244354667.USD","BK1583","LU2328871848.SGD","BK1589","01801","BK4585","LU0326950275.SGD","LU1188198961.HKD","KCAI","BK4588","LU1969619763.USD","LU0502904849.HKD","HK0000165453.HKD","KURE","LU2488822045.USD","LU2097828474.EUR","LU2097828714.EUR","LU2242644610.SGD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115078027","title":"HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1115078027","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115078027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:17","pubTimestamp":1787707028,"startTime":"0","endTime":"0","summary":"Key corporate developments this week: GenFleet Therapeutics-B (02595) has initiated a Phase II study evaluating GFH375, an oral KRAS G12D inhibitor, as a first-line treatment for non-small cell lung...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU2476274308.USD","LU0348784397.USD","LU1794554557.SGD","BK4585","LU2488822045.USD","LU0348766576.USD","09926","LU2476274720.SGD","LU2399975544.HKD","LU0540923850.HKD","BK1518","LU1961090484.USD","BK1586","IE00B5MMRT66.SGD","BK1574","BK1589","IE00B543WZ88.USD","LU0417516738.SGD","LU0348735423.USD","00660","LU1720050803.USD","LU0561508036.HKD","BK1526","KCAI","LU0634319403.HKD","IE00BPRC5H50.USD","BK1237","BK1161","VXUS","LU0348827113.USD","BK4588","LU0348783233.USD","LU0417516902.SGD","02595","KURE","BK1155","00354","LU0417516571.SGD","LU0348767384.USD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169767752","title":"JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1169767752","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169767752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:10","pubTimestamp":1787703042,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on August 20, JPMorgan increased its holding in INNOVENT BIO (01801) by 2.355 million shares.The purchase was executed at an average price of HK$102.2359...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","LU2430703251.USD","IE0034235188.USD","LU1116320737.USD","LU1917777945.USD","BK4504","IE00BWXC8680.SGD","IE00BHPRN162.USD","LU0187121727.USD","LU0208291251.USD","LU0971096721.USD","LU2505996509.AUD","LU2552382132.HKD","VFH","LU0211327993.USD","LU0496365809.HKD","LU0820562030.AUD","JPO","LU0244354667.USD","LU0320765646.SGD","BK4585","LU1116320901.HKD","LU0868494708.USD","UYG","IE00BFXG1179.USD","LU2237443895.HKD","LU1363072403.SGD","LU0203347892.USD","BK4534","LU1548497426.USD","LU0170899867.USD","BK4207","LU0234570918.USD","LU2552382215.SGD","LU0689472784.USD","TRUF","BK4566","LU0238689110.USD","LU2097828557.USD","LU1366192091.USD","FNCL","LU0683600562.USD","LU0211326839.USD","LU0326950275.SGD","LU2242649171.HKD","LU2552382058.USD","LU0345769631.USD","LU0256863902.USD","IE00BBT3K403.USD","LU1267930490.SGD","IE00B3S45H60.SGD","LU1720051017.SGD","LU0256863811.USD","LU0964807845.USD","IE00BJTD4V19.USD","LU2211815571.USD","XLF","LU1551013425.SGD","JPMO","LU1244550577.SGD","IYG","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU0345770308.USD","LU2237443622.USD","LU2756315664.SGD","LU0070302665.USD","IE00B1XK9C88.USD","01801","LU0310799852.SGD","LU1969619763.USD","LU0417517546.SGD","LU0211328371.USD","LU1119994496.HKD","LU2756315318.SGD","IYF","BK1161","LU1496350171.SGD","LU0502904849.HKD","LU1720051108.HKD","LU0942090050.USD","LU2023250504.SGD","BK4550","KBWB","LU1894683264.USD","LU2237443465.HKD","LU1894683348.USD","LU0211326755.USD","LU0345769128.USD","LU2430703178.SGD","LU2505996681.GBP","IE00BLSP4239.USD","LU2236285917.USD","LU2106854487.HKD","IE0034235303.USD","LU1496350502.SGD","LU1280957306.USD","LU2488822045.USD","LU1032466523.USD","LU2456880835.USD","LU2417539215.USD","LU1629891620.HKD","LU0345770993.USD","LU0265550946.USD","LU2054465674.USD","LU0265550359.USD","LU2023250330.USD","LU2237443978.SGD","JPM","LU0882574139.USD","LU2746668461.USD","LU0267386448.USD","LU0323591593.USD","LU2381873111.SGD","LU0640476718.USD","LU2023250843.SGD","IE00BKVL7J92.USD","LU1064131342.USD","LU2242644610.SGD","LU2357305700.SGD","IE00BDCRKT87.USD","LU1261432733.SGD","BK4588","SG9999002232.USD","LU0106261372.USD","LU1084165304.USD","HK0000165453.HKD","IE00BK4W5L77.USD","LU2462157665.USD","IE00BK4W5M84.HKD","LU0820561818.USD","LU2592432038.USD","LU2097828805.USD","LU1988902786.USD","LU0820561909.HKD","LU1162221912.USD","LU2746668974.SGD","LU0463099449.HKD","BK4516","BK4533","LU1914381329.SGD","LU2237443549.SGD","SG9999002224.SGD","IE00BDRTCR15.USD","LU0787776722.HKD","LU0943347566.SGD","LU0868494617.USD","BK1583","TFNS","IE00BJLML261.HKD","LU2097828714.EUR","LU0320765489.SGD","IE00BJTD4N35.SGD","LU0106831901.USD","LU1668664300.SGD","IE00BKDWB100.SGD","LU1974910355.USD","LU1244550494.USD","LU1244550221.USD","LU0149725797.USD","LU2430703095.HKD","LU0251132253.USD","LU2357627491.SGD","LU0859254822.USD","LU0215105999.USD","LU2328871848.SGD","LU0455707207.USD","LU1670628061.USD","LU0234572021.USD","LU1188198961.HKD","FTXO","LU0006306889.USD","LU0211331839.USD","LU2097828474.EUR","LU0203345920.USD","IE000M9KFDE8.USD","IE00B775SV38.USD","LU2213496289.HKD","LU2264538146.SGD","LU1670627923.USD","IE00BN8TJ469.HKD","IE00BZ1G4Q59.USD","IXG","EWH","LU1145028129.USD","LU2244417387.USD","LU0976567544.SGD","LU2097828631.EUR","BK4581","LU0048584097.USD","IE0034235295.USD","LU2237443382.USD","BK1589","IE00BYXW3230.USD","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197055899","title":"AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197055899","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197055899?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:42","pubTimestamp":1787701336,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, first-in-class bispecific antibody, 依达方® (ivonescimab, PD-1/VEGF), combined with chemotherapy, demonstrated a statistically significant...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","III","LU2476274308.USD","LU2778985437.USD","LU0417516571.SGD","LU0561508036.HKD","LU0540923850.HKD","LU0348767384.USD","LU0417516902.SGD","KURE","LU2488822045.USD","IE00BPRC5H50.USD","LU1961090484.USD","09926","IE00B543WZ88.USD","LU2476274720.SGD","LU1794554557.SGD","BK1574","LU0348735423.USD","LU0417516738.SGD","BK1161","LU0348827113.USD","LU0348766576.USD","LU0348784397.USD","LU0348825331.USD","LU0348783233.USD","LU1720050803.USD","LU0634319403.HKD","LU2399975544.HKD","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685897","title":"Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685897?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:01","pubTimestamp":1787698884,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","LU2399975544.HKD","LU1720050803.USD","LU1961090484.USD","LU2488822045.USD","IE00BPRC5H50.USD","LU2476274720.SGD","LU2476274308.USD","LU0634319403.HKD","LU0348766576.USD","LU0348783233.USD","KURE","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0561508036.HKD","LU0348767384.USD","LU0417516902.SGD","BK1161","LU0348827113.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU0348784397.USD","09926","LU1794554557.SGD","LU0348735423.USD","LU2778985437.USD","LU0417516571.SGD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662505547","title":"China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt","url":"https://stock-news.laohu8.com/highlight/detail?id=2662505547","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662505547?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:24","pubTimestamp":1787696645,"startTime":"0","endTime":"0","summary":"China's Clover Biopharma H1 revenue drops sharply, flags going-concern doubtOverviewChina vaccine developer's H1 revenue dropped sharply after ending AdimFlu-S (QIS) sales in ChinaCompany swung to net","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","LU2328871848.SGD","LU2097828474.EUR","BK1141","LU0455707207.USD","06118","LU2097828714.EUR","LU0326950275.SGD","LU2242644610.SGD","LU2097828557.USD","LU0463099449.HKD","02197","BK1161","BK1589","BK1583","LU1969619763.USD","KURE","01801","LU0244354667.USD","LU0502904849.HKD","LU2488822045.USD","LU2097828631.EUR","LU1188198961.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752407","title":"Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752407?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274720.SGD","LU2399975544.HKD","09926","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348766576.USD","LU0348767384.USD","LU2778985437.USD","LU1794554557.SGD","LU0348825331.USD","LU2476274308.USD","LU0561508036.HKD","LU0348827113.USD","LU0417516902.SGD","LU0417516571.SGD","LU1961090484.USD","BK1161","LU0417516738.SGD","LU0348783233.USD","LU0348784397.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0634319403.HKD","LU1720050803.USD","LU2488822045.USD","BK1574","KURE","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662524007","title":"Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662524007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662524007?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","LU0417516571.SGD","LU2476274720.SGD","LU1720050803.USD","BK1161","LU2778985437.USD","LU1794554557.SGD","LU0348825331.USD","09926","LU0348766576.USD","LU2476274308.USD","LU0348827113.USD","BK1574","LU0348735423.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0561508036.HKD","LU0348784397.USD","LU1961090484.USD","LU0417516738.SGD","LU2488822045.USD","LU0348767384.USD","LU0634319403.HKD","KURE","IE00B5MMRT66.SGD","LU0417516902.SGD","LU0540923850.HKD","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401752","title":"Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348766576.USD","LU0634319403.HKD","LU0348825331.USD","LU0348784397.USD","LU2476274308.USD","LU2476274720.SGD","LU0561508036.HKD","IE00BPRC5H50.USD","LU0348735423.USD","LU2488822045.USD","LU0348783233.USD","IE00B543WZ88.USD","LU1961090484.USD","09926","BK1161","KURE","LU2399975544.HKD","LU0540923850.HKD","LU0348767384.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU1720050803.USD","LU0417516902.SGD","LU1794554557.SGD","LU2778985437.USD","LU0348827113.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068756","title":"WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068756","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068756?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:22","pubTimestamp":1787674955,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) half year earnings in focus\nWuXi Biologics (Cayman) (SEHK:2269) reported half year 2026 earnings, noting higher sales, net income and earnings per share compared with the same period in 2025.\nSee our latest analysis for WuXi Biologics (Cayman).\nAlongside these half year results, WuXi Biologics (Cayman) has seen strong recent momentum, with a 30 day share price return of 33.5% and a 90 day share price return of 54.99%, while the 1 year total shareholder return is...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0039217434.USD","LU0359201612.USD","LU0128526141.USD","LU1794554557.SGD","SG9999002562.SGD","BK1521","IE00B0JY6N72.USD","LU0326950275.SGD","LU0572944931.SGD","BK1576","LU0823426480.USD","LU1242518931.SGD","KURE","LU0052750758.USD","LU0327786744.USD","LU0979878070.USD","LU0320764599.SGD","LU0516423174.USD","LU0348735423.USD","LU0307460666.USD","LU0819121731.USD","BK1141","LU0708995583.HKD","BK1610","LU1242518857.USD","SG9999002463.SGD","LU0456827905.SGD","LU0456846285.SGD","LU1720050803.USD","LU0417516738.SGD","LU0516422952.EUR","LU0140636845.USD","LU0181495838.USD","LU1880383366.USD","LU0043850808.USD","LU0348825331.USD","LU0516422440.USD","LU0516422366.SGD","BK1589","LU0051755006.USD","LU3063872942.SGD","LU0359202008.SGD","LU0588546209.SGD","LU2039709279.SGD","LU0029874061.USD","LU0856984785.SGD","02269","LU1688375341.USD","LU0417516902.SGD","LU0823426308.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}